<DOC>
	<DOCNO>NCT00432302</DOCNO>
	<brief_summary>The purpose study : ) Determine body take test drug distribute various body organ tissue , process drug ultimately remove ; b ) Examine well test drug work cancer , whether safe tolerable take</brief_summary>
	<brief_title>Investigation Mass Balance Test Drug Major Metabolites</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany .</detailed_description>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Male ≥ 18 year ; female ≥ 50 year without childbearing potential ( confirm either : age ≥ 60 ; history hysterectomy ; hormone analysis serum : Estradiol ≤ 20 pg/mL follicle stimulate hormone ≥ 40 IU/L ) Solid tumor Adequate function major organ Failed previous cancer treatment Peripheral venous access Concurrent severe and/or uncontrolled disease Brain tumor Marked constipation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Tumor</keyword>
	<keyword>Malignancy</keyword>
	<keyword>Mass Balance</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Drug</keyword>
	<keyword>Cancer Treatment</keyword>
	<keyword>Intravenous Infusion</keyword>
	<keyword>Epothilone</keyword>
	<keyword>Solid Tumor</keyword>
</DOC>